Signum Biosciences, Inc. is a biopharmaceutical company spun out of Princeton University focused on the discovery and development of innovative products to address major consumer and medical needs. Signum develops compounds and botanical extracts that are mimetics of natural lipid ligands crucial to cellular regulation and signaling.
Signum’s science and IP involve key lipid chemistries and the signaling loci they modulate. The company’s research and development effort build upon two-decades of basic research at the Princeton University laboratory of Professor Jeffry B. Stock, co-founder of Signum Biosciences.